Truist cuts Charles Schwab stock target to $84, maintains Buy

Published 21/04/2025, 11:48
Truist cuts Charles Schwab stock target to $84, maintains Buy

On Monday, Truist Securities made adjustments to its outlook on Charles Schwab Corp (BVMF:SCHW34). (NYSE: SCHW) shares, reducing the price target from $85.00 to $84.00 while keeping a Buy rating on the stock. The revision comes in the wake of the company’s quarterly performance and recent comments from management. According to InvestingPro data, 11 analysts have recently revised their earnings estimates upward for the upcoming period, with price targets ranging from $65 to $103.

The analyst at Truist Securities, David Smith, has chosen to keep the GAAP EPS estimates for Charles Schwab (NYSE:SCHW) steady for the years 2025 and 2026 at $4.05 and $4.70, respectively. The new price target reflects a lower P/E multiple, which Smith attributes to heightened economic uncertainty. Currently trading at a P/E ratio of 23.09, InvestingPro analysis suggests the stock is slightly undervalued, with strong growth potential supported by a 10.86% revenue increase in the last twelve months.

The updated model from Truist takes into account the quarter’s performance and includes expectations for higher fee income. However, this is balanced by a slight increase in expenses and a modestly higher share count resulting from lower share buybacks. The adjustment in share count is due to a refinement in the firm’s Available-for-Sale (AOCI) modeling methodology. With a market capitalization of $138.28 billion and impressive gross profit margins of 97.05%, Charles Schwab remains a prominent player in the Capital Markets industry.

Smith’s comments highlighted the changes in the model, explaining, "We update our Schwab model after the quarter to reflect the performance in the quarter and latest management commentary. We leave our GAAP EPS estimates unchanged in aggregate for 2025 and 2026 at $4.05 and $4.70, respectively. We reduce our price target to $84 (from $85) on a lower P/E multiple to reflect greater economic uncertainty."

The decision by Truist to maintain a Buy rating indicates their continued confidence in Charles Schwab’s stock despite the slight reduction in the price target. This suggests that the firm believes the stock still has potential for growth and that the underlying business remains strong.

In other recent news, Charles Schwab reported first-quarter earnings that exceeded expectations, with adjusted earnings per share (EPS) of $1.04 surpassing the consensus estimate of $1.01. The company’s revenue also exceeded forecasts by 1.1%, translating to an additional $58 million. Analysts at Citi and JMP Securities remain optimistic, maintaining Buy and Market Outperform ratings with price targets of $102 and $94, respectively. Barclays (LON:BARC) and JPMorgan also expressed confidence, each maintaining an Overweight rating with price targets of $84 and $92. Charles Schwab recently made a strategic minority investment in Wealth.com, an estate planning platform, to enhance its wealth management services. This investment aims to broaden Schwab’s offerings, particularly in trust and estate services. Additionally, Schwab’s introduction of Alternative OneSource is expected to drive Return On Client Assets growth. These developments reflect Schwab’s efforts to strengthen its financial health and expand its client services.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.